• To be able to perform specialist assessment, treatment and counselling of patients with mesothelioma

  • Awareness of the existence of different pathological subtypes of mesothelioma and the availability of different diagnostic procedures

  • Appreciation that mesothelioma causes morbidity and mortality by local invasion

  • Awareness of the importance of the multimodality approach to treat patients with mesothelioma

  • Awareness of the principles of the multimodality approach with early-stage disease

  • Appreciation of established scoring systems for predicting prognosis

  • Knowledge of the implications of the extent of mesothelioma for the selection of appropriate treatments and the usual sequence in which they are given

  • Familiarity with the different presentations of mesothelioma, as well as the tests available for work-up and staging

  • Familiarity with the indications for and limitations of the different diagnostic tools available for the identification of mesothelioma (including fine needle aspiration (FNA), bronchoscopy)

  • Familiarity with the indications and value of surgery, radiation therapy and chemotherapy in mesothelioma, but also with their limitations (eg, criteria of operability)

  • Understanding of the role of chemotherapy, and radiation therapy in the management of patients with advanced disease

  • Knowledge which complications arise from disease progression and which are treatment-associated

  • Familiarity with various surgical techniques and when they are indicated

  • Familiarity with supportive and palliative care strategies

  • Ability to perform a history and physical examination and to interpret imaging studies to appropriately stage mesothelioma patients

  • Ability to effectively identify and present relevant information about the patient at multidisciplinary settings

  • Ability to contribute to discussions on general management strategies in order to understand the rationale for selecting and sequencing treatments in a multidisciplinary setting

  • Ability to effectively discuss data with patients regarding the impact of various treatments, and what would be recommended for them specifically

  • Ability to identify situations where surgery, radiation or multimodality therapy is preferred over systemic therapy alone

  • Ability to select therapy according to pathological subtype, extent of disease and performance status

  • Ability to minimise and manage side effects from surgery, radiation or systemic therapies

  • Ability to guide a patient discussion about continuing anticancer therapy versus pursuing supportive care only